Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Journey Medical Corporation (DERM) vs Lifecore Biomedical, Inc. (LFCR)

Journey Medical Corporation and Lifecore Biomedical, Inc. are both Drug Manufacturers Specialty & Generic companies. Journey Medical Corporation and Lifecore Biomedical, Inc. are of similar size ($178.4M and $162.4M). Journey Medical Corporation grew revenue faster over the last twelve months: 20.9% against −10.0%. Journey Medical Corporation has the higher net margin (−8.95% vs −37.5%) and the lower return on invested capital (−5.89% vs −2.80%). Across the 17 metrics below, Journey Medical Corporation leads on 10 and Lifecore Biomedical, Inc. on 7.

Valuation

Metric DERM LFCR Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 2.48 1.32 2.25
P/B 5.26 n/m 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA 96.75 n/m 12.29
EV/Sales 2.47 2.73 2.56
Earnings yield (3.58%) (23.10%) (2.99%)
Free cash flow yield (13.32%) (3.21%) 0.00%

Profitability

Metric DERM LFCR Drug Manufacturers Specialty & Generic median
Gross margin 65.45% 26.86% 53.94%
Operating margin (4.41%) (6.89%) 0.00%
Net margin (8.95%) (37.54%) 0.00%
Free cash flow margin (10.99%) (4.24%) 0.00%
Return on equity (23.77%) 201.15% (0.40%)
Return on assets (6.80%) (19.32%) (3.32%)
Return on invested capital (5.89%) (2.80%) 0.00%

Growth

Metric DERM LFCR Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 20.89% (10.03%) 10.01%
EPS growth (last fiscal year) 34.72% (439.33%) —
Revenue growth, 5-year CAGR 6.79% (4.24%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DERM LFCR Drug Manufacturers Specialty & Generic median
Debt to equity 0.79 11.50 0.05
Current ratio 1.59 3.87 2.31
Net debt to EBITDA (0.35) (15.59) 0.85

Dividend

Metric DERM LFCR Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric DERM LFCR Drug Manufacturers Specialty & Generic median
Market cap 178.38m 162.39m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack